Sakar Healthcare Ltd. (SAKAR): Sakar Healthcare Share Price Rises 8% Today to Rs 1,095

Sakar Healthcare Share Price is at Rs 1,095, up 8% today, with market capitalisation of Rs 2,255.92 Cr. The move places Sakar Healthcare Ltd. among the more closely watched names in healthcare stock news today.

Sakar Healthcare Share Price is rising today after the stock moved to Rs 1,095 from a previous close of Rs 1,013.90. The share price gain of 8% lifted market capitalisation to Rs 2,255.92 Cr, making Sakar Healthcare Stock News relevant for traders tracking Indian Stock Market moves and healthcare sector activity. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst.

Sakar Healthcare Share Price Today: Price Action Analysis

For readers comparing Sakar Healthcare Share Price Today with broader market updates, the move is straightforward: the stock opened at Rs 1,021, touched a low of Rs 1,018.95 and reached Rs 1,095 during the trading window. Turnover stood at Rs 23.24 Cr, showing active interest without changing the fact that the rally itself needs to be judged from price action, valuation and sector context. In this Sakar Healthcare Stock Analysis, the main question is whether the rise is supported by fundamentals and how it compares with peers in Pharmaceuticals & Drugs.

Metric	Value
Current Price	Rs 1,095
Previous Close	Rs 1,013.9
Today's Move	Rs 81.1 (+8%)
Open	Rs 1,021
High	Rs 1,095
Low	Rs 1,018.95
Turnover	Rs 23.24 crore
Market Capitalisation	Rs 2,255.92 crore
Market Cap Category	Small Cap

Sakar Healthcare Ltd. (SAKAR) rose to Rs 1,095 from the previous close of Rs 1,013.9, a move of Rs 81.1 or 8%. The stock opened at Rs 1,021, reached a high of Rs 1,095, recorded a low of Rs 1,018.95.

As of 07 September 2026 at 12:53:15 PM IST, Sakar Healthcare Share Price was last traded at Rs 1,095, up Rs 81.10 or 8% from the previous close of Rs 1,013.90. The stock opened at Rs 1,021, moved between Rs 1,018.95 and Rs 1,095, and finished this live update at the day high. The turnover of Rs 23.24 Cr shows meaningful market activity around the move.

For anyone searching Sakar Healthcare Share Price Live, the key point is that the stock is trading near the top of its observed range for the day. That keeps Sakar Healthcare Stock Gaining Today firmly in focus across Stocks in News and Top Gainers Today searches.

Sakar Healthcare Ltd. (SAKAR) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,255.92 crore
P/E Ratio	62.49x
P/B Ratio	6.74x
ROE	6.48%
ROCE	8.43%
EPS	Rs 16.22
Book Value Per Share	Rs 150.44
Dividend Yield	0%

Sakar Healthcare Ltd. (SAKAR) fundamental metrics show P/E 62.49x, P/B 6.74x, ROE 6.48%, ROCE 8.43%. These figures provide context only and are not a buy or sell signal.

Sakar Healthcare Ltd. has a market capitalisation of Rs 2255.92 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.49x, P/B at 6.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 6.48% and ROCE of 8.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 16.22, book value per share of Rs 150.44, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	62.49x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	6.74x
Benchmark Median P/B	2.92x
Company ROE	6.48%
Benchmark Median ROE	11.78%
Company ROCE	8.43%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 2,255.92 crore
Benchmark Median Market Cap	Rs 674.09 crore

Sakar Healthcare Ltd. (SAKAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Sakar Healthcare Ltd. (SAKAR) has a P/E ratio of 62.49x, which is above the benchmark median of 32.83x, a difference of +90.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sakar Healthcare Ltd. (SAKAR) has a ROE of 6.48%, which is below the benchmark median of 11.78%, a difference of -44.99%. Sakar Healthcare Ltd. (SAKAR) has a ROCE of 8.43%, which is below the benchmark median of 13.65%, a difference of -38.24%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Sakar Healthcare Ltd. (SAKAR) has a P/E ratio of 62.49x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 6.48% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 8.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sakar Healthcare Ltd. (SAKAR) has a market capitalisation of Rs 2,255.92 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Sakar Healthcare

• Sakar Healthcare Share Price has risen 8% today, taking attention to the latest price action.
• The stock is trading at Rs 1,095, which keeps Sakar Healthcare Share Price Today in active focus.
• Market cap of Rs 2,255.92 Cr gives the move size and context for Stock Market Today trackers.
• P/E of 62.49 and P/B of 6.74 make the valuation question central to Sakar Healthcare Fundamental Analysis.
• ROE of 6.48% and ROCE of 8.43% remain below the industry benchmark, which matters in sector comparison.

About Sakar Healthcare

Sakar Healthcare Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s market profile is tied to how it participates in pharma-related business, and its stock is listed on NSE and BSE under the symbol SAKAR. Based on the latest Univest figures, the share price move today is best understood against a backdrop of company size, valuation and return ratios rather than a disclosed catalyst.

For investors following Sakar Healthcare Company News, the important business lens is whether the company can improve earnings quality over time. EPS at Rs 16.22 and book value at Rs 150.44 provide reference points for that discussion, while dividend yield at 0 means the current appeal is not income-led. In that sense, Sakar Healthcare Stock Performance today is mostly about how the market is pricing future expectations versus present fundamentals.

Frequently Asked Questions

Why is Sakar Healthcare Share Price rising today?

Ans. Sakar Healthcare Share Price is up 8% to Rs 1,095, with Rs 2,255.92 Cr market cap and Rs 23.24 Cr turnover. The latest Univest figures confirm the move but do not establish a company-specific catalyst.

What is Sakar Healthcare Share Price Today?

Ans. Sakar Healthcare Share Price Today is Rs 1,095. It moved from a previous close of Rs 1,013.90 and traded between Rs 1,018.95 and Rs 1,095 during the live market window.

How much did Sakar Healthcare stock rise today?

Ans. Sakar Healthcare stock rose Rs 81.10, which equals 8%. That move placed the share price at Rs 1,095, making it a notable healthcare stock move in today’s market.

What is Sakar Healthcare market capitalisation now?

Ans. Sakar Healthcare market capitalisation stands at Rs 2,255.92 Cr. This helps frame the company’s size and compares it with larger healthcare peers such as Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals.

Is Sakar Healthcare expensive on valuation?

Ans. Sakar Healthcare trades at a P/E of 62.49 and a P/B of 6.74, both above the industry median and average. That makes valuation richer than the sector norm on current numbers.

How do Sakar Healthcare fundamentals compare with peers?

Ans. Sakar Healthcare’s ROE of 6.48% and ROCE of 8.43% are below most named peers, while its P/E is higher than Cipla and Zydus Lifesciences. The comparison leans toward premium valuation with weaker returns.

What do EPS and book value show for Sakar Healthcare?

Ans. EPS is Rs 16.22 and book value is Rs 150.44. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share behind Sakar Healthcare Share Price.

Where can investors track Sakar Healthcare Share Price live?

Ans. Investors can track Sakar Healthcare Share Price live on Univest for price updates, ratio checks, sector context and market cap. The platform also helps compare Sakar Healthcare with listed pharma peers and industry benchmarks.

Track Sakar Healthcare Share Price on Univest

Use Sakar Healthcare Ltd. (SAKAR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track Sakar Healthcare Share Price on Univest for live price updates, Sakar Healthcare Stock News, Sakar Healthcare Latest News, company ratios, market capitalisation, sector comparison and benchmark checks. Univest also helps readers follow Sakar Healthcare Share Price Today alongside peer context, valuation and market insights.

If you are watching Sakar Healthcare Share Price Live, Univest is a useful place to review the stock’s movement, ratio profile and broader healthcare context in one view.